دورية أكاديمية
SGLT2-hæmmere til type 1-diabetes ; SGLT 2 inhibitors in Type 1 diabetes
| العنوان: | SGLT2-hæmmere til type 1-diabetes ; SGLT 2 inhibitors in Type 1 diabetes |
|---|---|
| المؤلفون: | Stougaard, Elisabeth Buur, Amadid, Hanan, Søndergaard, Esben, Jørgensen, Marit Eika, Persson, Frederik, Rossing, Peter |
| المصدر: | Stougaard , E B , Amadid , H , Søndergaard , E , Jørgensen , M E , Persson , F & Rossing , P 2021 , ' SGLT2-hæmmere til type 1-diabetes ' , Ugeskrift for Læger , bind 182 , nr. 1 , V05200351 . < https://ugeskriftet.dk/videnskab/sglt2-haemmere-til-type-1-diabetesTest > |
| سنة النشر: | 2021 |
| المجموعة: | University of Southern Denmark: Research Output / Syddansk Universitet |
| الوصف: | The sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin has been approved for the treatment of Type 1 diabetes (T1D) with significant reductions in HbA1c, weight, total daily insulin dose and significant increase in time in range without an increased risk of hypoglycaemia. The use of SGLT2i in T1D has, however, shown a significant increase from 1,9% to 4,0% in the risk of diabetic ketoacidosis (DKA), which may present as euglycaemic DKA. In this review we therefore find it important to know, that DKA may present with normal/near-normal blood glucose levels, if the patient is treated with an SGLT2i. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | Danish |
| العلاقة: | https://portal.findresearcher.sdu.dk/da/publications/92252e64-b45c-44a1-bc3e-17d8bdc701b2Test |
| الإتاحة: | https://portal.findresearcher.sdu.dk/da/publications/92252e64-b45c-44a1-bc3e-17d8bdc701b2Test https://ugeskriftet.dk/videnskab/sglt2-haemmere-til-type-1-diabetesTest |
| حقوق: | info:eu-repo/semantics/closedAccess |
| رقم الانضمام: | edsbas.995C5001 |
| قاعدة البيانات: | BASE |
| الوصف غير متاح. |